CHA Biotech
Scope
Date
~
-
Private equity
Mirae Assets logs 150% return from German biotech startup exit
Mirae Asset Daewoo Co. Ltd. has earned a 150% return on a $15 million investment in German biotechnology firm BioNTech SE in nine months, securing $22...
Apr 17, 2020 (Gmt+09:00)
-
Private Equity
Korean biotech fund reaps triple-digit return on two Nasdaq-listed firms
South Korea’s $25 million biotechnology-themed fund, launched by Meritz Securities Co. Ltd., has earned triple-digit returns on its 2.7 billion ...
Jan 21, 2020 (Gmt+09:00)
-
Unison Capital agrees to sell Gong Cha to US PEF for $300 mn
South Korea-based Unison Capital Inc. has signed a definitive agreement to sell milk tea brand Gong Cha to US private equity firm TA Associates for ar...
Aug 26, 2019 (Gmt+09:00)
-
Unison Capital in final stages of talks to sell Gong Cha to US PEF
Unison Capital Inc. is in the final stages of negotiations to sell Taiwan-style milk tea brand Gong Cha to US private equity firm TA Associates for ar...
Jul 31, 2019 (Gmt+09:00)
-
KB Investment joins $134 mn funding for Swiss biotech venture
KB Investment Co. Ltd., the venture capital arm of KB Financial Group, has invested $10 million in a Swiss biotech start-up firm which recently raised...
Jul 20, 2019 (Gmt+09:00)
-
Unison Capital puts bubble tea franchise Gong Cha up for sale
Private equity firm Unison Capital Inc. has put bubble tea franchise Gong Cha on the market, a deal estimated at up to $442 million, as the South Kore...
Jan 23, 2019 (Gmt+09:00)